IFNA1 and neoplasm: Owing to the tumor tropism properties, MSCs have been engineered to express various antitumor factors, such as IFN-α, TRAIL, and IL-12, and these genetically modified MSCs have shown dramatically therapeutic prospects [5, 17, 18].